Philadelphia, PA – eviti, Inc. announces that Heather Curry, M.D. has joined eviti as Medical Director, Radiation Oncology. Dr. Curry will oversee radiation oncology treatment plan review for adherence to national standards and interface with treating physicians and payers. As part of the eviti Medical Office team, her role is integral to assuring both providers and payers that radiation treatments conform to the highest quality and reflect the most recent clinical data.
“We’re delighted to have Dr. Curry on board,” said Arlene Forastiere, M.D., SVP, Medical Affairs at eviti, Inc., “she brings a wealth of experience in academic and community care settings to our team, and she’ll play a valuable role in providing our users with actionable radiation oncology decision support.”
Curry joins eviti with over 15 years of experience in oncology, including nearly ten years as a radiation oncologist at Paoli Hospital Cancer Center where she served on numerous committees, including the Physician Advisory Group, Cancer Committee, and Radiation Safety Committee. She was an Assistant Professor at Thomas Jefferson University Hospital’s Radiation Oncology Department, and is certified by the American Board of Radiology. Dr. Curry is also eligible for certification in Hospice and Palliative Medicine.
She is a member of the American society for Therapeutic Radiology and Oncology, the American College of Radiology, and the American Association of Hospice and Palliative Medicine. Dr. Curry has been named a “Top Physician” in Radiation Oncology by Main Line Today Magazine for the last three years.
Curry earned her A.B. from Bryn Mawr College where she graduated Magna Cum Laude with Honors in Philosophy and a minor in Biology. She received her medical degree from Temple University School of Medicine and completed her radiation oncology residency at Washington University in St. Louis.
About eviti, Inc.
eviti, Inc. is a leading health information technology and clinical decision-support company delivering solutions to improve the quality of cancer care and reduce its cost. eviti represents the culmination of almost a decade of experience providing oncology treatment intelligence, uniquely delivering value to all parties in the care process by ensuring quality care is prescribed from the start.
eviti’s growing national prominence is evidenced by the 2,000+ oncology practices already registered to use the eviti platform. eviti’s independent, non-proprietary digital oncology treatment library is one of the most comprehensive and current of its kind, meticulously compiled from the world’s leading sources. eviti’s treatment knowledge base and patent-pending decision-support engine help oncologists select a treatment option that is both evidence-based and compliant with each patient’s insurance plan language at the moment of prescribing. This transparent approach streamlines workflow and reimbursement, reduces variability in clinical care, and results in cost efficiencies. eviti allows the best cancer care to be available everywhere. For more information, visit www.eviti.com.